Previous close | 18.70 |
Open | 18.40 |
Bid | 18.20 x 300000 |
Ask | 18.50 x 300000 |
Day's range | 18.30 - 18.50 |
52-week range | 17.50 - 51.50 |
Volume | |
Avg. volume | 7 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 04 Nov 2024 - 11 Nov 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DUBLIN, August 29, 2024--Prothena today announced that members of its senior management team will participate in two upcoming investor conferences in September 2024.
Prothena (PRTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
We recently compiled a list of the 7 Best Debt Free Stocks To Buy. In this article, we are going to take a look at where Prothena Corporation plc (NASDAQ:PRTA) stands against the other debt free stocks. Debt has always been the fuel driving many companies in the equity markets. Access to cheap capital when […]